Chemoinformaics analysis of GAMMA-GLUTAMYL-S-ALLYLCYSTEINE
| Molecular Weight | 290.341 | nRot | 10 |
| Heavy Atom Molecular Weight | 272.197 | nRig | 4 |
| Exact Molecular Weight | 290.094 | nRing | 0 |
| Solubility: LogS | -1.757 | nHRing | 0 |
| Solubility: LogP | -2.625 | No. of Aliphatic Rings | 0 |
| Acid Count | 2 | No. of Aromatic Rings | 0 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 37 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 0 |
| nHetero | 8 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 0 |
| nHA | 5 | APOL | 39.4823 |
| nHD | 4 | BPOL | 23.1217 |
| QED | 0.32 |
| Synth | 3.252 |
| Natural Product Likeliness | 0.571 |
| NR-PPAR-gamma | 0.117 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.026 |
| HIA | 0.022 |
| CACO-2 | -6.302 |
| MDCK | 0.00000358 |
| BBB | 0.241 |
| PPB | 0.271266 |
| VDSS | 0.329 |
| FU | 0.602239 |
| CYP1A2-inh | 0.002 |
| CYP1A2-sub | 0.023 |
| CYP2c19-inh | 0.04 |
| CYP2c19-sub | 0.038 |
| CYP2c9-inh | 0.205 |
| CYP2c9-sub | 0.553 |
| CYP2d6-inh | 0.024 |
| CYP2d6-sub | 0.147 |
| CYP3a4-inh | 0.018 |
| CYP3a4-sub | 0.005 |
| CL | 2.772 |
| T12 | 0.833 |
| hERG | 0.011 |
| Ames | 0.015 |
| ROA | 0.019 |
| SkinSen | 0.119 |
| Carcinogencity | 0.053 |
| EI | 0.051 |
| Respiratory | 0.148 |
| NR-Aromatase | 0.009 |
| Antiviral | No |
| Prediction | 0.591668 |